Capitalisation of R&D and the informativeness of stock prices: Pre- and post-IFRS evidence
dc.contributor.author | Dargenidou, C | |
dc.contributor.author | Jackson, RHG | |
dc.contributor.author | Tsalavoutas, I | |
dc.contributor.author | Tsoligkas, F | |
dc.date.accessioned | 2021-03-09T11:40:38Z | |
dc.date.issued | 2021-03-04 | |
dc.description.abstract | We examine whether requiring (IFRS) versus allowing (UK GAAP) conditional capitalisation of development expenditure affects the extent to which capitalisation conveys more information about future earnings, relative to expensing. We show that capitalisation results in current returns incorporating more future earnings information than expensing under UK GAAP but not under IFRS. i.e., the amount of information incorporated into market prices of capitalisers is the same as that from firms expensing R&D under IFRS. This result holds irrespective of a firm’s earnings management incentives or strength of corporate governance for the period under IFRS. We argue that this is because investors experience greater uncertainty regarding the realisation of future economic benefits associated with the development costs capitalised in the post-IFRS period. Consistent with this, we do find a positive association between capitalised R&D and future earnings variability in the post-IFRS period only, as well as short-term positive abnormal returns for capitalisers relative to expensers in the pre-IFRS period only. Overall, these findings suggest that when moving from a standard that offers an overt option to capitalise or expense, capitalisation comes with greater uncertainty, which is resolved only in the long term. | en_GB |
dc.identifier.citation | Published online 4 March 2021 | en_GB |
dc.identifier.doi | 10.1016/j.bar.2021.100998 | |
dc.identifier.uri | http://hdl.handle.net/10871/125073 | |
dc.language.iso | en | en_GB |
dc.publisher | Elsevier | en_GB |
dc.rights.embargoreason | Under embargo until 4 March 2023 in compliance with publisher policy | en_GB |
dc.rights | © 2021. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_GB |
dc.subject | Research and development | en_GB |
dc.subject | IFRS adoption | en_GB |
dc.subject | IAS 38 | en_GB |
dc.subject | SSAP 13 | en_GB |
dc.title | Capitalisation of R&D and the informativeness of stock prices: Pre- and post-IFRS evidence | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2021-03-09T11:40:38Z | |
dc.identifier.issn | 0890-8389 | |
dc.description | This is the author accepted manuscript. The final version is available from Elsevier via the DOI in this record | en_GB |
dc.identifier.journal | The British Accounting Review | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_GB |
dcterms.dateAccepted | 2021-02-28 | |
rioxxterms.version | AM | en_GB |
rioxxterms.licenseref.startdate | 2021-02-28 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2021-03-09T01:41:55Z | |
refterms.versionFCD | P | |
refterms.panel | C | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2021. This version is made available under the CC-BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0/